Bio-Techne Corporation Total Liabilities 2011-2026 | TECH

Annual Total Liabilities Bio-Techne Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	719 M	514 M	609 M	250 M	216 M	67.2 M	40.6 M	44.9 M	31.5 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
719 M	31.5 M	277 M

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Allakos ALLK	74.8 M	-	-	$ 28.6 M	USA
Advaxis ADXS	7.89 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
AlloVir ALVR	42.9 M	-	4.14 %	$ 49.1 M	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Ampio Pharmaceuticals AMPE	2.38 M	-	-11.43 %	$ 502 K	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	4.9 M	$ 0.89	1.48 %	$ 6.54 M	China
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	455 M	$ 22.2	-2.07 %	$ 3.68 B	USA
Evogene Ltd. EVGN	8.07 M	$ 0.75	-4.66 %	$ 27.9 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Applied Molecular Transport AMTI	46.6 M	-	-	$ 10.1 M	USA
Galapagos NV GLPG	171 M	$ 27.87	-1.94 %	$ 2.69 B	Belgium
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Applied Therapeutics APLT	72 M	-	-	$ 8.42 M	USA
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
ImmuCell Corporation ICCC	15.5 M	$ 8.41	0.72 %	$ 75.9 M	USA
Innoviva INVA	383 M	$ 23.04	-2.74 %	$ 1.55 B	USA
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Innate Pharma S.A. IPHA	151 M	$ 1.49	6.43 %	$ 235 M	France
Inventiva S.A. IVA	226 M	$ 4.93	-1.5 %	$ 138 M	France
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
Aravive ARAV	51.5 M	-	-13.39 %	$ 1.45 M	USA
Aridis Pharmaceuticals ARDS	38.9 M	-	17.91 %	$ 11.1 M	USA
Atreca BCEL	76.6 M	-	-11.76 %	$ 5.79 M	USA
BioNTech SE BNTX	2.76 B	$ 100.87	-1.17 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	137 M	-	-4.8 %	$ 255 M	USA
Kamada Ltd. KMDA	32 M	$ 8.17	0.25 %	$ 260 M	Israel
Aquestive Therapeutics AQST	194 M	$ 4.05	-0.98 %	$ 433 M	USA
Arcutis Biotherapeutics ARQT	243 M	$ 22.46	-3.56 %	$ 2.86 B	USA
Fennec Pharmaceuticals FENC	35.1 M	$ 6.33	-5.6 %	$ 181 M	USA
Autolus Therapeutics plc AUTL	411 M	$ 1.41	-5.07 %	$ 375 M	Britain
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
AVROBIO AVRO	6.35 M	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 2.98	2.76 %	$ 4.91 M	Israel
Madrigal Pharmaceuticals MDGL	657 M	$ 516.16	-0.1 %	$ 11.6 B	USA
BeiGene, Ltd. BGNE	3.83 B	-	0.49 %	$ 251 B	Cayman-islands
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	470 M	-	-	$ 867 M	Germany